Pfizer has become the first pharmaceutical company to participate in President Donald Trump’s Most Favored Nation pricing, which requires the company to offer medications at a discount and invest in production in the United States.

Pfizer’s products will be offered on a website that hasn’t yet launched, called TrumpRx.gov. The program, at least initially, seems to be geared toward patients who access care through Medicaid. But officials said during a press conference they see a future where these prices will also apply in the Medicare program and commercial plans.

In July, Trump had sent letters to the heads of pharmaceutical companies outlining steps for lowering drug costs by matching them to prices in other developed nations. To determine those prices, the administration started with

See Full Page